225 related articles for article (PubMed ID: 3080861)
1. Hemodynamic factors limiting the response to transdermal nitroglycerin in severe chronic congestive heart failure.
Packer M; Medina N; Yushak M; Lee WH
Am J Cardiol; 1986 Feb; 57(4):260-7. PubMed ID: 3080861
[TBL] [Abstract][Full Text] [Related]
2. Isosorbide dinitrate for the relief of severe heart failure after myocardial infarction.
Mantle JA; Russell RO; Moraski RE; Rackley CE
Am J Cardiol; 1976 Feb; 37(2):263-8. PubMed ID: 1108634
[TBL] [Abstract][Full Text] [Related]
3. Hemodynamic and hormonal effects of high-dose transdermal nitroglycerin in patients with chronic congestive heart failure.
Elkayam U; Roth A; Henriquez B; Weber L; Tonnemacher D; Rahimtoola SH
Am J Cardiol; 1985 Sep; 56(8):555-9. PubMed ID: 3929585
[TBL] [Abstract][Full Text] [Related]
4. Comparative hemodynamic effects of chewable isosorbide dinitrate and nitroglycerin in patients with congestive heart failure.
Mikulic E; Franciosa JA; Cohn JN
Circulation; 1975 Sep; 52(3):477-82. PubMed ID: 808359
[TBL] [Abstract][Full Text] [Related]
5. Sustained beneficial hemodynamic responses to large doses of transdermal nitroglycerin in congestive heart failure and comparison with intravenous nitroglycerin.
Rajfer SI; Demma FJ; Goldberg LI
Am J Cardiol; 1984 Jul; 54(1):120-5. PubMed ID: 6430054
[TBL] [Abstract][Full Text] [Related]
6. Hemodynamic assessment of oral peripheral vasodilator therapy in chronic congestive heart failure: prolonged effectiveness of isosorbide dinitrate.
Williams DO; Bommer WJ; Miller RR; Amsterdam EA; Mason DT
Am J Cardiol; 1977 Jan; 39(1):84-90. PubMed ID: 318795
[TBL] [Abstract][Full Text] [Related]
7. Hemodynamic and metabolic effects of isosorbide dinitrate in chronic congestive heart failure.
Gray R; Chatterjee K; Vyden JK; Ganz W; Forrester JS; Swan HJ
Am Heart J; 1975 Sep; 90(3):346-52. PubMed ID: 1163426
[TBL] [Abstract][Full Text] [Related]
8. Hemodynamic advantage of combined administration of hydralazine orally and nitrates nonparenterally in the vasodilator therapy of chronic heart failure.
Massie B; Chatterjee K; Werner J; Greenberg B; Hart R; Parmley WW
Am J Cardiol; 1977 Nov; 40(5):794-801. PubMed ID: 411364
[TBL] [Abstract][Full Text] [Related]
9. Prevention of tolerance to hemodynamic effects of nitrates with concomitant use of hydralazine in patients with chronic heart failure.
Gogia H; Mehra A; Parikh S; Raman M; Ajit-Uppal J; Johnson JV; Elkayam U
J Am Coll Cardiol; 1995 Dec; 26(7):1575-80. PubMed ID: 7594088
[TBL] [Abstract][Full Text] [Related]
10. [New aspects of the treatment of left ventricular failure: Nitroglycerin (author's transl)].
Bussmann WD
Med Klin; 1975 Oct; 70(42):1697-1706. PubMed ID: 810653
[TBL] [Abstract][Full Text] [Related]
11. Hemodynamic effects of isosorbide dinitrate vs nitroglycerin in patients with unstable angina.
Willis WH; Russell RO; Mantle JA; Ratshin RA; Rackley CE
Chest; 1976 Jan; 69(1):15-22. PubMed ID: 811427
[TBL] [Abstract][Full Text] [Related]
12. Comparative evaluation of a new formulation of isosorbide dinitrate oral spray and sublingual nitroglycerin tablets.
Marmor A
Am J Cardiol; 1990 Jun; 65(21):43J-45J. PubMed ID: 2112337
[TBL] [Abstract][Full Text] [Related]
13. Comparative effects of captopril and isosorbide dinitrate on pulmonary arteriolar resistance and right ventricular function in patients with severe left ventricular failure: results of a randomized crossover study.
Packer M; Medina N; Yushak M; Lee WH
Am Heart J; 1985 Jun; 109(6):1293-9. PubMed ID: 3890506
[TBL] [Abstract][Full Text] [Related]
14. Effect of isosorbide dinitrate on cardiac output in severe cardiac failure: relation to initial hemodynamics, ventricular volume, and the preload reserve mechanism.
Lewis BS; Hardoff R; Halon DA
Clin Cardiol; 1989 Sep; 12(9):514-20. PubMed ID: 2791373
[TBL] [Abstract][Full Text] [Related]
15. Randomized study to evaluate the relation between oral isosorbide dinitrate dosing interval and the development of early tolerance to its effect on left ventricular filling pressure in patients with chronic heart failure.
Elkayam U; Roth A; Mehra A; Ostrzega E; Shotan A; Kulick D; Jamison M; Johnston JV; Rahimtoola SH
Circulation; 1991 Nov; 84(5):2040-8. PubMed ID: 1934379
[TBL] [Abstract][Full Text] [Related]
16. [The acute, chronic continuous after treatment and chronic intermittent with a variable therapeutic window (4 and 6 hours) hemodynamic effects induced with transdermal nitroglycerin in patients with congestive heart failure].
Nodari S; Metra M; Gei P; Danesi R; Furloni R; Cuminetti S; Dei Cas L
Cardiologia; 1991 Jun; 36(6):451-60. PubMed ID: 1769029
[TBL] [Abstract][Full Text] [Related]
17. [Effect of sublingual isosorbide dinitrate on hemodynamics in coronary patients with and without congestive heart failure (author's transl)].
Wolf R; Beck OA; Habel F; Hochrein H
Z Kardiol; 1977 Aug; 66(8):459-64. PubMed ID: 899150
[TBL] [Abstract][Full Text] [Related]
18. Effect of isosorbide dinitrate on response to submaximal and maximal exercise in patients with congestive heart failure.
Franciosa JA; Cohn JN
Am J Cardiol; 1979 May; 43(5):1009-14. PubMed ID: 433762
[TBL] [Abstract][Full Text] [Related]
19. Hemodynamic and hormonal response to transdermal nitroglycerin in normal subjects and in patients with congestive heart failure.
Olivari MT; Carlyle PF; Levine TB; Cohn JN
J Am Coll Cardiol; 1983 Nov; 2(5):872-8. PubMed ID: 6415142
[TBL] [Abstract][Full Text] [Related]
20. Vasodilator therapy for chronic left ventricular failure.
Kovick RB; Tillisch JH; Berens SC; Bramowitz AD; Shine KI
Circulation; 1976 Feb; 53(2):322-8. PubMed ID: 812614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
